Literature DB >> 18632595

Enhanced detection of low abundance human plasma proteins using a tandem IgY12-SuperMix immunoaffinity separation strategy.

Wei-Jun Qian1, David T Kaleta, Brianne O Petritis, Hongliang Jiang, Tao Liu, Xu Zhang, Heather M Mottaz, Susan M Varnum, David G Camp, Lei Huang, Xiangming Fang, Wei-Wei Zhang, Richard D Smith.   

Abstract

The enormous dynamic range of human bodily fluid proteomes poses a significant challenge for current MS-based proteomics technologies as it makes it especially difficult to detect low abundance proteins in human biofluids such as blood plasma, which is an essential aspect for successful biomarker discovery efforts. Here we present a novel tandem IgY12-SuperMix immunoaffinity separation system for enhanced detection of low abundance proteins in human plasma. The tandem IgY12-SuperMix system separates approximately 60 abundant proteins from the low abundance proteins in plasma, allowing for significant enrichment of low abundance plasma proteins in the SuperMix flow-through fraction. High reproducibility of the tandem separations was observed in terms of both sample processing recovery and LC-MS/MS identification results based on spectral count data. The ability to quantitatively measure differential protein abundances following application of the tandem separations was demonstrated by spiking six non-human standard proteins at three different levels into plasma. A side-by-side comparison between the SuperMix flow-through and IgY12 flow-through samples analyzed by both one- and two-dimensional LC-MS/MS revealed a 60-80% increase in proteome coverage as a result of the SuperMix separations, suggesting significantly enhanced detection of low abundance proteins. A total of 695 plasma proteins were confidently identified in a single analysis (with a minimum of two peptides per protein) by coupling the tandem separation strategy with two-dimensional LC-MS/MS, including 42 proteins with reported normal concentrations of approximately 100 pg/ml to 100 ng/ml. The concentrations of two selected proteins, macrophage colony-stimulating factor 1 and matrix metalloproteinase-8, were independently validated by ELISA as 202 pg/ml and 12.4 ng/ml, respectively. Evaluation of binding efficiency revealed that 45 medium abundance proteins were efficiently captured by the SuperMix column with >90% retention. Taken together, these results illustrate the potential broad utilities of this tandem IgY12-SuperMix strategy for proteomics applications involving human biofluids where effectively addressing the dynamic range challenge of the specimen is imperative.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18632595      PMCID: PMC2559934          DOI: 10.1074/mcp.M800008-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  25 in total

1.  Effect of immunoaffinity depletion of human serum during proteomic investigations.

Authors:  Anastasia K Yocum; Kenneth Yu; Tomoyuki Oe; Ian A Blair
Journal:  J Proteome Res       Date:  2005 Sep-Oct       Impact factor: 4.466

2.  Multidimensional liquid chromatography separation of intact proteins by chromatographic focusing and reversed phase of the human serum proteome: optimization and protein database.

Authors:  Simon Sheng; Dawn Chen; Jennifer E Van Eyk
Journal:  Mol Cell Proteomics       Date:  2005-09-27       Impact factor: 5.911

3.  Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins.

Authors:  Leigh Anderson; Christie L Hunter
Journal:  Mol Cell Proteomics       Date:  2005-12-06       Impact factor: 5.911

4.  Immunoaffinity separation of plasma proteins by IgY microbeads: meeting the needs of proteomic sample preparation and analysis.

Authors:  Lei Huang; Gulia Harvie; Jerald S Feitelson; Kosi Gramatikoff; David A Herold; David L Allen; Ravi Amunngama; Rachel A Hagler; Michael R Pisano; Wei-Wei Zhang; Xiangming Fang
Journal:  Proteomics       Date:  2005-08       Impact factor: 3.984

5.  Differences among techniques for high-abundant protein depletion.

Authors:  Nina Zolotarjova; James Martosella; Gordon Nicol; Jerome Bailey; Barry E Boyes; William C Barrett
Journal:  Proteomics       Date:  2005-08       Impact factor: 3.984

6.  Depletion efficiency and recovery of trace markers from a multiparameter immunodepletion column.

Authors:  Joachim Brand; Tobias Haslberger; Werner Zolg; Gabriele Pestlin; Stefan Palme
Journal:  Proteomics       Date:  2006-06       Impact factor: 3.984

Review 7.  Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications.

Authors:  Wei-Jun Qian; Jon M Jacobs; Tao Liu; David G Camp; Richard D Smith
Journal:  Mol Cell Proteomics       Date:  2006-08-03       Impact factor: 5.911

Review 8.  Protein biomarker discovery and validation: the long and uncertain path to clinical utility.

Authors:  Nader Rifai; Michael A Gillette; Steven A Carr
Journal:  Nat Biotechnol       Date:  2006-08       Impact factor: 54.908

9.  High dynamic range characterization of the trauma patient plasma proteome.

Authors:  Tao Liu; Wei-Jun Qian; Marina A Gritsenko; Wenzhong Xiao; Lyle L Moldawer; Amit Kaushal; Matthew E Monroe; Susan M Varnum; Ronald J Moore; Samuel O Purvine; Ronald V Maier; Ronald W Davis; Ronald G Tompkins; David G Camp; Richard D Smith
Journal:  Mol Cell Proteomics       Date:  2006-05-09       Impact factor: 5.911

10.  Correlation of relative abundance ratios derived from peptide ion chromatograms and spectrum counting for quantitative proteomic analysis using stable isotope labeling.

Authors:  Boris Zybailov; Michael K Coleman; Laurence Florens; Michael P Washburn
Journal:  Anal Chem       Date:  2005-10-01       Impact factor: 6.986

View more
  86 in total

Review 1.  Protein biomarkers of ovarian cancer: the forest and the trees.

Authors:  Brian M Nolen; Anna E Lokshin
Journal:  Future Oncol       Date:  2012-01       Impact factor: 3.404

2.  Combining ultracentrifugation and peptide termini group-specific immunoprecipitation for multiplex plasma protein analysis.

Authors:  Sonja Volk; Thomas D Schreiber; David Eisen; Calvin Wiese; Hannes Planatscher; Christopher J Pynn; Dieter Stoll; Markus F Templin; Thomas O Joos; Oliver Pötz
Journal:  Mol Cell Proteomics       Date:  2012-04-23       Impact factor: 5.911

3.  Enhanced sensitivity for selected reaction monitoring mass spectrometry-based targeted proteomics using a dual stage electrodynamic ion funnel interface.

Authors:  Mahmud Hossain; David T Kaleta; Errol W Robinson; Tao Liu; Rui Zhao; Jason S Page; Ryan T Kelly; Ronald J Moore; Keqi Tang; David G Camp; Wei-Jun Qian; Richard D Smith
Journal:  Mol Cell Proteomics       Date:  2010-04-21       Impact factor: 5.911

4.  Multiplexed, Quantitative Workflow for Sensitive Biomarker Discovery in Plasma Yields Novel Candidates for Early Myocardial Injury.

Authors:  Hasmik Keshishian; Michael W Burgess; Michael A Gillette; Philipp Mertins; Karl R Clauser; D R Mani; Eric W Kuhn; Laurie A Farrell; Robert E Gerszten; Steven A Carr
Journal:  Mol Cell Proteomics       Date:  2015-02-27       Impact factor: 5.911

5.  Combinatorial peptide ligand library treatment followed by a dual-enzyme, dual-activation approach on a nanoflow liquid chromatography/orbitrap/electron transfer dissociation system for comprehensive analysis of swine plasma proteome.

Authors:  Chengjian Tu; Jun Li; Rebeccah Young; Brian J Page; Frank Engler; Marc S Halfon; John M Canty; Jun Qu
Journal:  Anal Chem       Date:  2011-05-26       Impact factor: 6.986

6.  Utilizing spectral counting to quantitatively characterize tandem removal of abundant proteins (TRAP) in human plasma.

Authors:  Christopher M Shuford; Adam M Hawkridge; John C Burnett; David C Muddiman
Journal:  Anal Chem       Date:  2010-11-19       Impact factor: 6.986

Review 7.  Status and prospects for discovery and verification of new biomarkers of cardiovascular disease by proteomics.

Authors:  Robert E Gerszten; Aarti Asnani; Steven A Carr
Journal:  Circ Res       Date:  2011-08-05       Impact factor: 17.367

Review 8.  Serum biomarkers for diagnosis and prediction of type 1 diabetes.

Authors:  Lian Yi; Adam C Swensen; Wei-Jun Qian
Journal:  Transl Res       Date:  2018-08-01       Impact factor: 7.012

9.  Analysis of serum total and free PSA using immunoaffinity depletion coupled to SRM: correlation with clinical immunoassay tests.

Authors:  Tao Liu; Mahmud Hossain; Athena A Schepmoes; Thomas L Fillmore; Lori J Sokoll; Scott R Kronewitter; Grant Izmirlian; Tujin Shi; Wei-Jun Qian; Robin J Leach; Ian M Thompson; Daniel W Chan; Richard D Smith; Jacob Kagan; Sudhir Srivastava; Karin D Rodland; David G Camp
Journal:  J Proteomics       Date:  2012-02-13       Impact factor: 4.044

10.  Cerebrospinal fluid proteome of patients with acute Lyme disease.

Authors:  Thomas E Angel; Jon M Jacobs; Robert P Smith; Mark S Pasternack; Susan Elias; Marina A Gritsenko; Anil Shukla; Edward C Gilmore; Carol McCarthy; David G Camp; Richard D Smith; H Shaw Warren
Journal:  J Proteome Res       Date:  2012-08-31       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.